prolyl-phenylalanyl-arginine-4-nitroanilide has been researched along with caprylates in 1 studies
| Studies (prolyl-phenylalanyl-arginine-4-nitroanilide) | Trials (prolyl-phenylalanyl-arginine-4-nitroanilide) | Recent Studies (post-2010) (prolyl-phenylalanyl-arginine-4-nitroanilide) | Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) |
|---|---|---|---|---|---|
| 38 | 0 | 1 | 5,061 | 100 | 2,339 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnouf, T; Chou, ML; Herrera, M; León, G; Segura, Á; Vargas, M; Villalta, M; Wu, YW | 1 |
1 other study(ies) available for prolyl-phenylalanyl-arginine-4-nitroanilide and caprylates
| Article | Year |
|---|---|
Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity.
Topics: Caprylates; Chemical Fractionation; Chromatography; Enzyme-Linked Immunosorbent Assay; Factor XIIa; Humans; Immunoglobulin G; Oligopeptides; Plasma; Thrombin | 2015 |